| first_text=
Symposium: Architect ci 4100 - science on the side of the small and medium laboratory
04.9.2010, Borovets
Architect ci 4100 - science as a working reality
04.9.2010, Borovets
Abbott Diagnostics - present and future
04.9.2010, Borovets
Optimal control of structural joint damage by RA- results from 5 year trial X- ray remission after treatment with Adalimumab (HUMIRA)
BioRx.en - National on-line registry for monitoring of safety and efficacy of biological agent treatment in RA patients
8.11.2009, Sofia
Symposium: Kaletra tablet - new star Abbott
17.10.2008, Sofia
Key aspects in the application of HUMIRA
(ADALIMUMAB) during treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
26.09.2008, Sunny Beach
Strategic partnership client - supplier - present and future in the shifting world of In Vitro diagnostics
7.06.2008, Varna
Company presentation: Abbott Architect
Systems and Assays - Innovations for safer blood
27.09.2007, Varna
Symposium: AxSYM - new tests, proven reliability
22.09.2007, Borovets
Workshop – Diagnostics Division Brighter Lights in Hematology Diagnostics
28.09.2006, Sofia
Avoiding mistakes during biochemical and immonulogical tests with Abbott's integrated system - ARCHITECT CI 820
10.06.2005, Albena
|